Blood eosinophil percentage as a predictor of response to inhaled corticosteroid in bronchiectasis

ConclusionBaseline eosinophil count of 3.5% might serve as a marker to predict the benefits of ICS on exacerbation risk among patients with non-CF bronchiectasis.

Source: The Clinical Respiratory Journal - April 26, 2023 Category: Respiratory Medicine Authors: Wang Chun Kwok, Terence Chi Chun Tam, David Chi Leung Lam, Mary Sau Man Ip, James Chung Man Ho Tags: ORIGINAL ARTICLE Source Type: research